JPS54125663A - Carcinostatic agent and novel compound having carcinostatic activity - Google Patents

Carcinostatic agent and novel compound having carcinostatic activity

Info

Publication number
JPS54125663A
JPS54125663A JP3200778A JP3200778A JPS54125663A JP S54125663 A JPS54125663 A JP S54125663A JP 3200778 A JP3200778 A JP 3200778A JP 3200778 A JP3200778 A JP 3200778A JP S54125663 A JPS54125663 A JP S54125663A
Authority
JP
Japan
Prior art keywords
compound
carcinostatic
novel
effective
novel compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP3200778A
Other languages
Japanese (ja)
Other versions
JPS6261568B2 (en
Inventor
Setsuo Takeuchi
Mutsuyuki Kochi
Akira Kawarada
Shinichiro Esumi
Kazuya Sasaki
Shozo Kawabata
Tsuneo Saida
Yukio Inoue
Tadasu Yamamoto
Takaharu Sekine
Koji Amamiya
Katsumasa Saga
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kaken Pharmaceutical Co Ltd
RIKEN Institute of Physical and Chemical Research
Original Assignee
Kaken Pharmaceutical Co Ltd
Kaken Chemical Co Ltd
RIKEN Institute of Physical and Chemical Research
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kaken Pharmaceutical Co Ltd, Kaken Chemical Co Ltd, RIKEN Institute of Physical and Chemical Research filed Critical Kaken Pharmaceutical Co Ltd
Priority to JP3200778A priority Critical patent/JPS54125663A/en
Publication of JPS54125663A publication Critical patent/JPS54125663A/en
Publication of JPS6261568B2 publication Critical patent/JPS6261568B2/ja
Granted legal-status Critical Current

Links

Abstract

PURPOSE: To provide a low-toxic carcinostatic agent effective to SV40 virus-induced cancer, containing a phenylimidazolidine derivative, a phenyloxazolidine derivative (some of which are novel) or their pharmaceutically permissible acid addition salt as effective components.
CONSTITUTION: A carcinostatic agent for oral or parenteral administration, containing a compound I (R is H, formula II; X is O, N; R1 is lower alkyl, hydroxy- lower-alkyl; when X is N, R2 is R1; and when X is O, R2 does not exist) as an effective component. The compound I wherein R is III and X is O, i.e. the compound IV is novel. The preferable amount of the effective component in the preparation is 0.3W15.0 wt% for oral or transmucous administration, and 0.01W10 wt% for parenteral administration. The compound I e.g. a novel compound V, can be prepared from terephthaldehyde and N-methyl-ethanolamine.
COPYRIGHT: (C)1979,JPO&Japio
JP3200778A 1978-03-20 1978-03-20 Carcinostatic agent and novel compound having carcinostatic activity Granted JPS54125663A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP3200778A JPS54125663A (en) 1978-03-20 1978-03-20 Carcinostatic agent and novel compound having carcinostatic activity

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP3200778A JPS54125663A (en) 1978-03-20 1978-03-20 Carcinostatic agent and novel compound having carcinostatic activity

Publications (2)

Publication Number Publication Date
JPS54125663A true JPS54125663A (en) 1979-09-29
JPS6261568B2 JPS6261568B2 (en) 1987-12-22

Family

ID=12346811

Family Applications (1)

Application Number Title Priority Date Filing Date
JP3200778A Granted JPS54125663A (en) 1978-03-20 1978-03-20 Carcinostatic agent and novel compound having carcinostatic activity

Country Status (1)

Country Link
JP (1) JPS54125663A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0122417A2 (en) * 1983-03-18 1984-10-24 American Cyanamid Company Polymeric(((oxazolidinyl)alkyl)amino)anthraquinones
WO1996022668A1 (en) * 1995-01-16 1996-07-25 Negawatt Technologies Inc. Energy management control system
US5668446A (en) * 1995-01-17 1997-09-16 Negawatt Technologies Inc. Energy management control system for fluorescent lighting

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0122417A2 (en) * 1983-03-18 1984-10-24 American Cyanamid Company Polymeric(((oxazolidinyl)alkyl)amino)anthraquinones
WO1996022668A1 (en) * 1995-01-16 1996-07-25 Negawatt Technologies Inc. Energy management control system
US5668446A (en) * 1995-01-17 1997-09-16 Negawatt Technologies Inc. Energy management control system for fluorescent lighting
US5962989A (en) * 1995-01-17 1999-10-05 Negawatt Technologies Inc. Energy management control system

Also Published As

Publication number Publication date
JPS6261568B2 (en) 1987-12-22

Similar Documents

Publication Publication Date Title
JPS5671073A (en) Imidazole derivative
JPS5432460A (en) Cycloalkylidenemethylphenylacetic acid derivative and their preparation
JPS5767516A (en) Novel analgesic agent
JPS54125663A (en) Carcinostatic agent and novel compound having carcinostatic activity
JPS5489036A (en) Remedy and preventive for hypersensitivity to light
IE39679B1 (en) Methods and compositions for killing parasites of warm blooded animals
JPS5673046A (en) Decaprenylamine derivative
JPS54132239A (en) Anti-tumor agent
JPS5716852A (en) Nitrile derivative, its preparation, and fibrosis suppressing agent containing the same
ES477257A1 (en) Isoquinoline derivatives, their preparation and pharmaceutical compositions containing these compounds.
JPS5772913A (en) Remedy for cardiac infraction
JPS5569512A (en) Antispasmodic agent
JPS57181012A (en) Drug composed of polyprenyl compound
JPS5634625A (en) Antitumorigenic agent
JPS55145669A (en) 8,10-diazaprostanoic acid derivative and its preparation
JPS5742620A (en) Novel antiulcer agent
JPS57108016A (en) Antithrombotic agent
JPS5782314A (en) Carcinostatic agent
JPS5569569A (en) Carcinostatic
JPS5675427A (en) Antiarteriosclerotic agent containing procainamide hydrochloride
JPS5780315A (en) Absorption promotor for accelerating rectum absorption, base comprising it, and pharmaceutical preparation to be medicated to rectum
JPS5569510A (en) Carcinostatic agent
JPS57197220A (en) Muscle relaxant
JPS5673024A (en) Antihyperlipemic agent
JPS54126733A (en) Carcinostatic agent